Teladoc Health (NYSE:TDOC) PT Raised to $10.00

Teladoc Health (NYSE:TDOC – Get Free Report) had its target price hoisted by Jefferies Financial Group from $8.00 to $10.00 in a report issued on Tuesday, MarketBeat.com reports. The firm presently has a “hold” rating on the health services provider’s stock. Jefferies Financial Group’s price objective would indicate a potential upside of 9.83% from the [...]

featured-image

Teladoc Health ( NYSE:TDOC – Get Free Report ) had its target price hoisted by Jefferies Financial Group from $8.00 to $10.00 in a report issued on Tuesday, MarketBeat.

com reports. The firm presently has a “hold” rating on the health services provider’s stock. Jefferies Financial Group’s price objective would indicate a potential upside of 9.



83% from the stock’s current price. Several other brokerages have also recently issued reports on TDOC. Piper Sandler decreased their price target on shares of Teladoc Health from $25.

00 to $10.00 and set an “overweight” rating for the company in a research report on Tuesday, August 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a research note on Thursday, August 1st.

Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating on the stock in a research note on Friday, August 2nd.

Truist Financial lowered their target price on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating for the company in a report on Friday, August 2nd.

Finally, Barclays decreased their price objective on shares of Teladoc Health from $20.00 to $10.00 and set an “overweight” rating for the company in a report on Thursday, August 1st.

Fifteen equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, Teladoc Health has an average rating of “Hold” and an average price target of $12.31.

Read Our Latest Stock Analysis on TDOC Teladoc Health Price Performance Teladoc Health ( NYSE:TDOC – Get Free Report ) last issued its quarterly earnings data on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share for the quarter, topping the consensus estimate of ($0.

36) by $0.08. Teladoc Health had a negative net margin of 38.

54% and a negative return on equity of 10.25%. The business had revenue of $642.

44 million during the quarter, compared to analysts’ expectations of $649.34 million. Research analysts anticipate that Teladoc Health will post -0.

73 earnings per share for the current fiscal year. Insider Activity In other news, COO Michael Willem Waters sold 6,053 shares of the business’s stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $8.

14, for a total transaction of $49,271.42. Following the sale, the chief operating officer now owns 74,214 shares in the company, valued at approximately $604,101.

96. The sale was disclosed in a document filed with the SEC, which is accessible through this link . In related news, COO Michael Willem Waters sold 6,053 shares of the company’s stock in a transaction dated Friday, August 2nd.

The shares were sold at an average price of $8.14, for a total value of $49,271.42.

Following the transaction, the chief operating officer now owns 74,214 shares in the company, valued at approximately $604,101.96. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website .

Also, Director Thomas Mckinley purchased 4,000 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The stock was purchased at an average price of $7.69 per share, for a total transaction of $30,760.

00. Following the purchase, the director now owns 39,077 shares in the company, valued at $300,502.13.

The disclosure for this purchase can be found here . In the last 90 days, insiders have sold 57,819 shares of company stock worth $442,204. Corporate insiders own 0.

95% of the company’s stock. Hedge Funds Weigh In On Teladoc Health A number of hedge funds have recently bought and sold shares of the company. Allianz Asset Management GmbH lifted its stake in Teladoc Health by 15.

4% during the 4th quarter. Allianz Asset Management GmbH now owns 604,238 shares of the health services provider’s stock valued at $13,021,000 after acquiring an additional 80,805 shares during the period. Allspring Global Investments Holdings LLC lifted its stake in Teladoc Health by 74.

0% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 20,568 shares of the health services provider’s stock valued at $311,000 after acquiring an additional 8,750 shares during the period. Janney Montgomery Scott LLC lifted its stake in Teladoc Health by 188.

7% during the 1st quarter. Janney Montgomery Scott LLC now owns 31,594 shares of the health services provider’s stock valued at $477,000 after acquiring an additional 20,651 shares during the period. Vanguard Group Inc.

lifted its stake in Teladoc Health by 11.8% during the 4th quarter. Vanguard Group Inc.

now owns 17,515,127 shares of the health services provider’s stock valued at $377,451,000 after acquiring an additional 1,855,480 shares during the period. Finally, Pale Fire Capital SE bought a new position in Teladoc Health during the 4th quarter valued at about $8,960,000. Institutional investors own 76.

82% of the company’s stock. Teladoc Health Company Profile ( Get Free Report ) Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments.

The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. See Also Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter .

.